Dr Martens has maintained its full year guidance as it makes ‘good progress’ on US turnaround

R0007731

Footwear specialist Dr Martens has maintained its guidance for the full-year as sales rose during the third quarter thanks to a return to growth in the US and Asia Pacific.

For the 13 weeks to December 29, 2024, Dr Martens reported a 3% rise in group revenue on a constant currency basis to hit £267m.

 

Already have an account?

Want to read more?

Register for LIMITED guest access

Register now

Get premium access

£5 A MONTH for 3 months

Subscribe now